Researchers Probe Gene Therapy for Frontotemporal Dementia
Gene therapy has shown promise for treating a neurodegenerative disease known as frontotemporal dementia and a related condition called neuronal ceroid lipofuscinosis, according to new findings presented by researchers from the University of Alabama at Birmingham.
Frontotemporal dementia, or FTD, is a devastating disease in which patients have rapid and dramatic changes in behavior, personality and social skills. The age of onset for FTD is relatively young, usually striking patients in their mid- to late 50s. FTD is often caused when an individual has only one copy of the GRN gene, which encodes for a protein called progranulin. Progranulin production is cut in half in individuals with only one copy of GRN.
A mutation resulting in the loss of both copies of the GRN gene leads to an almost complete absence of progranulin, causing a condition called neuronal ceroid lipofuscinosis, which often strikes adults in their 20s. NCL causes blindness and seizures, and can lead to premature death.
Click here to read more.
Microsurgical and Radiological Anatomy of Cerebral Sulci, Gyri, and Ventricles: The Rhoton-de Oliveira Course for Surgical Applications
Nov. 13-15, 2019; Jacksonville, Fla.
Complex Endoscopic Endonasal Surgery of the Skull Base
Nov. 14-16, 2019; Pittsburgh
2019 New Frontiers in the Diagnosis and Management of Movement Disorders
Nov. 16, 2019; Chicago
9th World Congress of Neuroendoscopy
Nov. 21-24, 2019; Orlando, Fla.
Mayo Clinic Multidisciplinary Spine Care Conference 2019
Nov. 22-23, 2019; Amelia Island, Fla.